Responses
Cardiovascular and metabolic risk
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
Compose a Response to This Article
Other responses
No responses have been published for this article.